The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hamilton James C since 2021.
This trader's CIK number is 1830755.
At the time of last reporting, Hamilton James C was the Chief Medical Officer of Arrowhead Pharmaceuticals, Inc.. (stock ticker symbol ARWR).
Also see all insider trading activities at Arrowhead Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ARWR | 0 | $0 | 57,729 | $1,226,143 | 0 | $0 |
| 2024 | ARWR | 0 | $0 | 52,383 | $1,788,070 | 0 | $0 |
| 2023 | ARWR | 0 | $0 | 23,676 | $913,884 | 0 | $0 |
| 2022 | ARWR | 0 | $0 | 25,625 | $1,690,833 | 0 | $0 |
| 2021 | ARWR | 0 | $0 | 48,750 | $3,611,699 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-02 | ARWR | Sale | 15,000 | 25.00 | 375,000 |
| 2025-08-13 | ARWR | Sale | 611 | 20.00 | 12,220 |
| 2025-08-15 | ARWR | Sale | 9,389 | 20.00 | 187,780 |
| 2025-01-06 | ARWR | Sale | 32,729 | 19.89 | 651,143 |
| 2024-04-01 | ARWR | Sale | 6,000 | 28.03 | 168,180 |
| 2024-01-12 | ARWR | Sale | 7,940 | 36.92 | 293,144 |
| 2024-01-03 | ARWR | Sale | 6,300 | 32.54 | 205,020 |
| 2024-01-05 | ARWR | Sale | 32,143 | 34.90 | 1,121,726 |
| 2023-06-30 | ARWR | Sale | 3,000 | 35.53 | 106,590 |
| 2023-01-03 | ARWR | Sale | 10,338 | 39.05 | 403,647 |
| 2023-01-03 | ARWR | Sale | 10,338 | 39.05 | 403,647 |
| 2022-01-04 | ARWR | Sale | 19,375 | 67.07 | 1,299,558 |
| 2022-01-05 | ARWR | Sale | 6,250 | 62.60 | 391,275 |
| 2021-01-14 | ARWR | Sale | 10,000 | 81.39 | 813,950 |
| 2021-01-06 | ARWR | Sale | 19,375 | 71.87 | 1,392,481 |
| 2021-01-05 | ARWR | Sale | 19,375 | 72.53 | 1,405,268 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hamilton James C (Chief Medical Officer of Arrowhead Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.